Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep409 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Improving safety in diabetes management and reducing insulin errors in hospital – practically achievable or a utopian fantasy?

Burbridge Wyn , Braycotton Lynne , Puttanna Amar , Yadagiri Mahender , Ilsley Dee , Mukhopadhyay Sagnik , Munichoodappa Karthik , De Parijat

42 insulin related incidents were reported within our Trust in 2014. Subsequent Root Cause Analysis revealed numerous insulin errors, hyperglycemia mismanagement and highlighted significant deficits in diabetes knowledge amongst nursing staff. To address the above issues, new safety interventions were introduced and five key outcomes are:1. A new stand-alone insulin prescription chart introduced May’15 has seen insulin incidents dec...

ea0034p61 | Clinical practice/governance and case reports | SFEBES2014

Endocrine complications of thalassemia and its treatment: a local experience

Deller Serena , Mistry Radhika , Burbridge Wyn , Pancham Shivan , Wright Christine , De Parijat

Introduction: Treatment of β thalassemia major results in excessive iron deposition in most tissues including the endocrine glands.Aim: To find out the prevalence of endocrine complications in our thalassemia-endocrine clinic as set out by the UK thalassemia society guidelines.Methods: Clinic notes and electronic results of all patients attending Birmingham City Hospital for the 2-monthly thalassemia-endocrine MDT clinic (2010...

ea0048oc4 | Oral Communications | SFEEU2017

One year efficacy, safety and tolerability outcomes of endoscopic proximal intestinal exclusion therapy using the Endobarrier device: institution of the UK’s first National Health Service Endobarrier service for type 2 diabetes and obesity

Gupta Piya Sen , Yadagiri Mahender , Irwin Susan , Burbridge Wyn , Gandhi Hardeep , Alden Rachel , Bleasdale John , Fogden Ed , Anderson Mark , Ryder Bob

Introduction: Our institution leads a UK, multicentre, randomised controlled trial (REVISE-Diabesity ISRCTN00151053) investigating the interaction of Endobarrier therapy, a 60 cm endoscopically implanted proximal intestinal liner, with glucagon-like peptide-1 drug therapy.Aims: To evaluate whether acquired experience could translate into establishment of an effective and safe NHS Endobarrier service in patients with diabesity.Metho...